Logo image of GUTS

FRACTYL HEALTH INC (GUTS) Stock Fundamental Analysis

USA - NASDAQ:GUTS - US35168W1036 - Common Stock

1.23 USD
0 (0%)
Last: 10/31/2025, 8:00:01 PM
1.27 USD
+0.04 (+3.25%)
After Hours: 10/31/2025, 8:00:01 PM
Fundamental Rating

1

Taking everything into account, GUTS scores 1 out of 10 in our fundamental rating. GUTS was compared to 189 industry peers in the Health Care Equipment & Supplies industry. GUTS has a bad profitability rating. Also its financial health evaluation is rather negative. GUTS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GUTS has reported negative net income.
In the past year GUTS has reported a negative cash flow from operations.
GUTS had negative earnings in each of the past 5 years.
GUTS had a negative operating cash flow in each of the past 5 years.
GUTS Yearly Net Income VS EBIT VS OCF VS FCFGUTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -160.90%, GUTS is not doing good in the industry: 89.42% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -160.9%
ROE N/A
ROIC N/A
ROA(3y)-97.75%
ROA(5y)-92.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GUTS Yearly ROA, ROE, ROICGUTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

With a Gross Margin value of 58.82%, GUTS perfoms like the industry average, outperforming 57.67% of the companies in the same industry.
GUTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GUTS Yearly Profit, Operating, Gross MarginsGUTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

1

2. Health

2.1 Basic Checks

GUTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GUTS has more shares outstanding
The number of shares outstanding for GUTS has been increased compared to 5 years ago.
GUTS has a better debt/assets ratio than last year.
GUTS Yearly Shares OutstandingGUTS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
GUTS Yearly Total Debt VS Total AssetsGUTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -14.55, we must say that GUTS is in the distress zone and has some risk of bankruptcy.
GUTS has a worse Altman-Z score (-14.55) than 84.13% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.55
ROIC/WACCN/A
WACC8.13%
GUTS Yearly LT Debt VS Equity VS FCFGUTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 1.22 indicates that GUTS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.22, GUTS is doing worse than 82.01% of the companies in the same industry.
GUTS has a Quick Ratio of 1.22. This is a normal value and indicates that GUTS is financially healthy and should not expect problems in meeting its short term obligations.
GUTS has a worse Quick ratio (1.22) than 68.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
GUTS Yearly Current Assets VS Current LiabilitesGUTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for GUTS have decreased strongly by -50.19% in the last year.
GUTS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -85.71%.
EPS 1Y (TTM)-50.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.33%
Revenue 1Y (TTM)-85.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 8.29% on average over the next years. This is quite good.
The Revenue is expected to grow by 337.37% on average over the next years. This is a very strong growth
EPS Next Y0.8%
EPS Next 2Y15.3%
EPS Next 3Y10.02%
EPS Next 5Y8.29%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y451.79%
Revenue Next 5Y337.37%

3.3 Evolution

GUTS Yearly Revenue VS EstimatesGUTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2027 2028 2029 2030 50M 100M 150M
GUTS Yearly EPS VS EstimatesGUTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GUTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GUTS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GUTS Price Earnings VS Forward Price EarningsGUTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GUTS Per share dataGUTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.3%
EPS Next 3Y10.02%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GUTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRACTYL HEALTH INC

NASDAQ:GUTS (10/31/2025, 8:00:01 PM)

After market: 1.27 +0.04 (+3.25%)

1.23

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-18 2025-11-18
Inst Owners53.84%
Inst Owner Change-0.45%
Ins Owners2.94%
Ins Owner Change0%
Market Cap162.14M
Revenue(TTM)17.00K
Net Income(TTM)-99767000
Analysts85.45
Price Target6.9 (460.98%)
Short Float %5.29%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-28%
Min EPS beat(2)-55.23%
Max EPS beat(2)-0.78%
EPS beat(4)1
Avg EPS beat(4)-16.83%
Min EPS beat(4)-55.23%
Max EPS beat(4)5.88%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.4%
PT rev (3m)-27.57%
EPS NQ rev (1m)7.06%
EPS NQ rev (3m)13.03%
EPS NY rev (1m)2.43%
EPS NY rev (3m)2.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9537.56
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.06
EYN/A
EPS(NY)-1.03
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS0
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -160.9%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.82%
FCFM N/A
ROA(3y)-97.75%
ROA(5y)-92.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 100%
Cap/Sales 5835.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z -14.55
F-Score2
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)132.87%
Cap/Depr(5y)81.29%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.33%
EPS Next Y0.8%
EPS Next 2Y15.3%
EPS Next 3Y10.02%
EPS Next 5Y8.29%
Revenue 1Y (TTM)-85.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y451.79%
Revenue Next 5Y337.37%
EBIT growth 1Y-39.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-18.19%
EBIT Next 3Y-14.78%
EBIT Next 5Y-8.7%
FCF growth 1Y-88.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-87.18%
OCF growth 3YN/A
OCF growth 5YN/A

FRACTYL HEALTH INC / GUTS FAQ

What is the fundamental rating for GUTS stock?

ChartMill assigns a fundamental rating of 1 / 10 to GUTS.


Can you provide the valuation status for FRACTYL HEALTH INC?

ChartMill assigns a valuation rating of 0 / 10 to FRACTYL HEALTH INC (GUTS). This can be considered as Overvalued.


How profitable is FRACTYL HEALTH INC (GUTS) stock?

FRACTYL HEALTH INC (GUTS) has a profitability rating of 0 / 10.


What is the financial health of FRACTYL HEALTH INC (GUTS) stock?

The financial health rating of FRACTYL HEALTH INC (GUTS) is 1 / 10.


What is the expected EPS growth for FRACTYL HEALTH INC (GUTS) stock?

The Earnings per Share (EPS) of FRACTYL HEALTH INC (GUTS) is expected to grow by 0.8% in the next year.